Sun Pharma launches cough syrup Chericof 12 in India

Mumbai: Pharma major, Sun Pharmaceutical Industries Ltd., today announced the launch of a novel formulation in cough management - Chericof 12 (Dextromethorphan Hydrobromide 30 mg and Chlorpheniramine Maleate 4 mg) in India.

Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug.

Chericof 12 is approved for patients of age group six years and above. All cough syrups generally give relief for 6-8 hours, and hence a patient has to take it three to four times a day. Frequent dosing often leads to patient inconvenience and non-adherence to follow the regimen, which may compromise the efficacy of the medication and disturb the daily lifestyle.

As per a study, a twice-a-day dosing regimen was associated with significantly better compliance in 70% of patients than threetimes a day (52%) and four-times a day (42%) dosing regimen, respectively . The Polistirex technology used in Chericof 12 provides sustained release of the medicine in the body, thus offering up to 12 hour relief to patients with twice-daily dosage.